17.01.2019 Views

Molecular Diagnostics Market Is Expected To Reach US$ 12,358.6 Mn By 2025

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> <strong>Is</strong> <strong>Expected</strong> <strong>To</strong> <strong>Reach</strong> <strong>US$</strong><br />

<strong>12</strong>,<strong>358.6</strong> <strong>Mn</strong> <strong>By</strong> <strong>2025</strong><br />

The latest market report published by Credence Research, Inc. “Global <strong>Molecular</strong><br />

<strong>Diagnostics</strong> <strong>Market</strong> - <strong>Market</strong> Growth, Future Prospects, Competitive Analysis, 2017<br />

- <strong>2025</strong>,” the global molecular diagnostics market was valued at <strong>US$</strong> 6,077.9 <strong>Mn</strong> in<br />

2016, and is expected to reach <strong>US$</strong> <strong>12</strong>,<strong>358.6</strong> <strong>Mn</strong> by <strong>2025</strong> expanding at a CAGR of<br />

7.8 % from 2017 to <strong>2025</strong>.<br />

<strong>Market</strong> Insights<br />

<strong>Molecular</strong> diagnostics has undergone tremendous technological advancement due<br />

to the growing need for personalized medication, rapid diagnosis to determine<br />

antibiotic regimen in order to prevent drug resistance and for the in-depth study of<br />

pandemic diseases such as Cholera, Swine flu, Dengue and Hepatitis A.<br />

Browse the full report Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong> - Growth, Future<br />

Prospects, Competitive Analysis, 2017 – <strong>2025</strong><br />

at https://www.credenceresearch.com/report/molecular-diagnostic-market<br />

In 2016, the reagents and kits held the largest revenue share for the product<br />

segment due to factors such as increasing number of clinics and laboratories<br />

performing diagnosis, rising public awareness leading to early disease diagnosis and<br />

treatment, and government initiatives to promote public health and welfare.<br />

Instruments will be the fastest growing segment among the considered products<br />

throughout the forecast period 2017-<strong>2025</strong> as they are undergoing tremendous<br />

modifications corresponding to specific requirements and inbuilt applications make<br />

it easy for the skilled workforce to perform accurate diagnosis in lesser span of<br />

time.


Infectious disease diagnostics is the leading the segment among the application<br />

areas due to factors such as increasing number of infectious disease, and growing<br />

demand for infectious disease diagnosis in tropical countries as the weather favors<br />

the microbes and vectors transmitting such diseases. Oncology will be the fastest<br />

growing segment in the application market through the forecast period 2017-<strong>2025</strong>,<br />

majorly due to factors such as rising prevalence of cancer, increasing demand for<br />

pharmacogenomics and technological advancement in the molecular diagnostic<br />

devices. Polymerase chain reaction holds the largest market in the technology<br />

segment for the base year 2016 due to factors such as its potential to detect rare<br />

diseases, rising demand for personalized medication and pharmacogenomics, and<br />

its potential in establishing the DNA sequence of patients, which will be helpful in<br />

the prevention of several life threatening diseases. Microarray will be the fastest<br />

growing technology segment throughout the forecast period 2017-<strong>2025</strong> as it is<br />

helpful in diagnosing different types of cancer on the basis of the genetic pattern<br />

and increasing demand for toxicogenomics, which helps in determining the<br />

antibiotics of choice in cases of multiple drug resistance.<br />

Download Free PDF Sample Request:<br />

https://www.credenceresearch.com/sample-request/58588<br />

The global molecular diagnostics market is technologically driven and includes<br />

major players such as Abbott Laboratories, Inc., Novartis AG, Alere, Inc., Siemens<br />

Healthcare, Bayer AG, and F.Hoffman La Roche Ltd. etc. are few market leaders in<br />

molecular diagnostic market and compete to augment their foothold in the<br />

market.<br />

Key <strong>Market</strong> Movements:<br />

- Rising prevalence of patients suffering with critical illnesses requiring immediate<br />

diagnosis<br />

- Increase in the number of research and academic institutes utilizing diagnostic<br />

reagents and instruments<br />

- Technological advancement in the nature of diagnostic reagents and kits<br />

providing better results<br />

- Affordable reimbursement scenario


<strong>By</strong> Product<br />

<br />

<br />

<br />

Reagents and Kits<br />

Instruments<br />

Services and Software<br />

<strong>By</strong> Application<br />

<br />

<br />

<br />

<br />

<br />

<br />

Infectious Diseases<br />

Oncology<br />

Next Generation Sequencing<br />

DNA Sequencing<br />

Microbiology<br />

Others<br />

<strong>By</strong> Technology<br />

<br />

<br />

<br />

<br />

<br />

Polymerase Chain Reaction (PCR)<br />

<strong>Is</strong>othermal Nucleic Acid Amplification Technology<br />

In situ Hybridization<br />

Microarrays<br />

Others<br />

<strong>By</strong> Geography<br />

<br />

<br />

<br />

<br />

<br />

North America<br />

Europe<br />

Asia Pacific<br />

Middle East & Africa (MEA)<br />

Latin America<br />

Download Free PDF Request for Customization:<br />

https://www.credenceresearch.com/inquiry-before-buying/58588


About Us<br />

Credence Research is a worldwide market research and counseling firm that serves<br />

driving organizations, governments, non legislative associations, and not-forbenefits.<br />

We offer our customers some assistance with making enduring<br />

enhancements to their execution and understand their most imperative objectives.<br />

Over almost a century, we've manufactured a firm extraordinarily prepared to this<br />

task.<br />

Media Contact<br />

Name: Chris Smith<br />

Address: 105 N 1st ST #429,<br />

SAN JOSE, CA 95103 US<br />

E-mail: sales@credenceresearch.com<br />

Ph.: 1-800-361-8290<br />

Website: http://www.credenceresearch.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!